Assignee
IMMUNOMEDICS INC
US·348 granted patents·132 pending applications·17,136 citations·filing 1983–2025
Top patents by PatentIndex Score
480 records- 0199US11541047B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2020·Granted Jan 3, 2023·5 cites·16 claims
- 0299US9492566B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2015·Granted Nov 15, 2016·61 cites·22 claims
- 0399US7999083B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2009·Granted Aug 16, 2011·184 cites·13 claims
- 0499US7931903B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2010·Granted Apr 26, 2011·97 cites·38 claims
- 0599US7772373B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2007·Granted Aug 10, 2010·114 cites·35 claims
- 0699US7662378B2Antibody therapyIMMUNOMEDICS INC·Filed 2007·Granted Feb 16, 2010·73 cites·18 claims
- 0799US7641901B2Immunotherapy of autoimmune disorders using antibodies which target B-cellsIMMUNOMEDICS INC·Filed 2005·Granted Jan 5, 2010·76 cites·47 claims
- 0899US7591994B2Camptothecin-binding moiety conjugatesIMMUNOMEDICS INC·Filed 2008·Granted Sep 22, 2009·129 cites·14 claims
- 0999US7563433B2Methods and compositions for F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2008·Granted Jul 21, 2009·64 cites·16 claims
- 1099US7312318B2Internalizing anti-CD74 antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Dec 25, 2007·243 cites·23 claims
- 1199US7109304B2Humanized anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2004·Granted Sep 19, 2006·240 cites·4 claims
- 1299US7074403B1Immunotherapy of autoimmune disorders using antibodies which target B-cellsIMMUNOMEDICS INC·Filed 2000·Granted Jul 11, 2006·226 cites·20 claims
- 1399US6653104B2Immunotoxins, comprising an internalizing antibody, directed against malignant and normal cellsIMMUNOMEDICS INC·Filed 2001·Granted Nov 25, 2003·346 cites·140 claims
- 1499US6472511B1Stimulation of an immune response with antibodies labeled with the α-galactosyl epitopeIMMUNOMEDICS INC·Filed 2000·Granted Oct 29, 2002·160 cites·5 claims
- 1599US6331175B1Method and kit for imaging and treating organs and tissuesIMMUNOMEDICS INC·Filed 1998·Granted Dec 18, 2001·239 cites·15 claims
- 1699US6306393B1Immunotherapy of B-cell malignancies using anti-CD22 antibodiesIMMUNOMEDICS INC·Filed 1999·Granted Oct 23, 2001·674 cites·33 claims
- 1799US6183744B1Immunotherapy of B-cell malignancies using anti-CD22 antibodiesIMMUNOMEDICS INC·Filed 1998·Granted Feb 6, 2001·386 cites·23 claims
- 1899US5697902AMethod for imaging and treating organs and tissuesIMMUNOMEDICS INC·Filed 1995·Granted Dec 16, 1997·289 cites·14 claims
- 1999US4925648ADetection and treatment of infectious and inflammatory lesionsIMMUNOMEDICS INC·Filed 1988·Granted May 15, 1990·518 cites·16 claims
- 2098US11116846B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2020·Granted Sep 14, 2021·8 cites·16 claims
- 2198US11020489B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2020·Granted Jun 1, 2021·4 cites·16 claims
- 2298US10849986B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2020·Granted Dec 1, 2020·5 cites·15 claims
- 2398US10682347B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2018·Granted Jun 16, 2020·11 cites·18 claims
- 2498US10137196B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2016·Granted Nov 27, 2018·18 cites·20 claims
- 2598US9187561B2Humanized anti-HLA-DR antibodiesIMMUNOMEDICS INC·Filed 2014·Granted Nov 17, 2015·35 cites·21 claims
- 2698US9138485B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2014·Granted Sep 22, 2015·32 cites·15 claims
- 2798US9028833B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2013·Granted May 12, 2015·48 cites·22 claims
- 2898US8992917B2Humanized L243 antibodiesIMMUNOMEDICS INC·Filed 2013·Granted Mar 31, 2015·37 cites·23 claims
- 2998US8759496B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2012·Granted Jun 24, 2014·38 cites·16 claims
- 3098US7993626B2Methods and compositions for F-18 labeling of proteins, peptides and other moleculesIMMUNOMEDICS INC·Filed 2008·Granted Aug 9, 2011·37 cites·16 claims
- 3198US7910103B2Immunotherapy of B-cell malignancies using anti-CD22 antibodiesIMMUNOMEDICS INC·Filed 2001·Granted Mar 22, 2011·77 cites·22 claims
- 3298US7902338B2Anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2008·Granted Mar 8, 2011·47 cites·11 claims
- 3398US7585491B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2003·Granted Sep 8, 2009·148 cites·40 claims
- 3498US7541440B2Chimeric, human and humanized anti-granulocyte antibodies and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Jun 2, 2009·129 cites·24 claims
- 3598US7462352B2Methods of treatng B-cell diseases using humanized anti-CD19 antibodiesIMMUNOMEDICS INC·Filed 2006·Granted Dec 9, 2008·74 cites·21 claims
- 3698US7300655B2Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereofIMMUNOMEDICS INC·Filed 2003·Granted Nov 27, 2007·109 cites·19 claims
- 3798US7282567B2Monoclonal antibody hPAM4IMMUNOMEDICS INC·Filed 2003·Granted Oct 16, 2007·143 cites·43 claims
- 3898US7238785B2RS7 antibodiesIMMUNOMEDICS INC·Filed 2003·Granted Jul 3, 2007·237 cites·8 claims
- 3998US7151164B2Anti-CD20 antibodies and fusion proteins thereof and methods of useIMMUNOMEDICS INC·Filed 2003·Granted Dec 19, 2006·290 cites·16 claims
- 4098US6962702B2Production and use of novel peptide-based agents for use with bi-specific antibodiesIMMUNOMEDICS INC·Filed 2001·Granted Nov 8, 2005·126 cites·30 claims
- 4198US6187287B1Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 1998·Granted Feb 13, 2001·402 cites·34 claims
- 4298US6096289AIntraoperative, intravascular, and endoscopic tumor and lesion detection, biopsy and therapyIMMUNOMEDICS INC·Filed 1998·Granted Aug 1, 2000·274 cites·23 claims
- 4398US5789554AImmunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cellsIMMUNOMEDICS INC·Filed 1996·Granted Aug 4, 1998·596 cites·32 claims
- 4498US5716595AIntraperative, intravascular and endoscopic tumor and lesion detection and therapy with monovalent antibody fragmentsIMMUNOMEDICS INC·Filed 1994·Granted Feb 10, 1998·307 cites·52 claims
- 4598US5443953APreparation and use of immunoconjugatesIMMUNOMEDICS INC·Filed 1993·Granted Aug 22, 1995·338 cites·17 claims
- 4697US10653793B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2018·Granted May 19, 2020·8 cites·11 claims
- 4797US10195175B2Synergistic effect of anti-Trop-2 antibody-drug conjugate in combination therapy for triple-negative breast cancer when used with microtubule inhibitors or PARP inhibitorsIMMUNOMEDICS INC·Filed 2017·Granted Feb 5, 2019·18 cites·12 claims
- 4897US10130626B2Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicityIMMUNOMEDICS INC·Filed 2016·Granted Nov 20, 2018·18 cites·16 claims
- 4997US10130718B2Antibody-drug conjugates and uses thereofIMMUNOMEDICS INC·Filed 2016·Granted Nov 20, 2018·12 cites·10 claims
- 5097US10064957B2Immunoconjugates with an intracellularly-cleavable linkageIMMUNOMEDICS INC·Filed 2017·Granted Sep 4, 2018·14 cites·24 claims
Showing the top 50 of 480 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when IMMUNOMEDICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →